Literature DB >> 3300179

Erythropoietin in haemangioblastoma: immunohistochemical and electron microscopy studies.

H Kamitani, H Masuzawa, J Sato, I Kanazawa.   

Abstract

Immunohistochemical studies for erythropoietin were carried out in six capillary haemangioblastomas, three of which were also studied by electron microscopy. The immunohistochemical studies showed that positively stained cells were scattered in the vicinity of capillaries, and that neither endothelial cells nor stromal cells were stained. In their morphology and distribution, the positively stained cells were identical to mast cells as observed by electron microscopy. In one case, erythropoietin was demonstrated in the cyst fluid of the tumour. These findings suggest that mast cells with abundant secreting granules in haemangioblastomas are capable of producing erythropoietin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3300179     DOI: 10.1007/BF01402372

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  25 in total

1.  The association of polycythemia with a cerebellar hemangioblastoma. The production of an erythropoiesis stimulating factor by the tumor.

Authors:  T A WALDMANN; E H LEVIN; M BALDWIN
Journal:  Am J Med       Date:  1961-08       Impact factor: 4.965

2.  Contribution of immunohistochemistry to diagnostic problems of human cerebral tumors.

Authors:  L F Eng; L J Rubinstein
Journal:  J Histochem Cytochem       Date:  1978-07       Impact factor: 2.479

3.  Ultrastructure of a hemangiopericytoma and a glomus tumor.

Authors:  T M Murad; E von Haam; M S Murthy
Journal:  Cancer       Date:  1968-12       Impact factor: 6.860

4.  [Ultrastructure of hem- angioblastomas of the central nervous system].

Authors:  P Castaigne; M David; B Pertuiset; R Escourolle; J Poirier
Journal:  Rev Neurol (Paris)       Date:  1968-01       Impact factor: 2.607

5.  Ultrastructural study on long-term cultures of bone marrow cells with histamine-producing stimulating factor (HCSF).

Authors:  B Nabarra; M Dy
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1984

6.  Mast cells and tumor angiogenesis.

Authors:  D A Kessler; R S Langer; N A Pless; J Folkman
Journal:  Int J Cancer       Date:  1976-11-15       Impact factor: 7.396

7.  Ultrastructure of mast cells in growing and involuting stages of hemangiomas.

Authors:  K A Pasyk; W C Grabb; G W Cherry
Journal:  Hum Pathol       Date:  1983-02       Impact factor: 3.466

8.  Cerebellar hemangioblastoma: erythropoietic activity by radioiron assay.

Authors:  T G Hennessy; W E Stern; S E Herrick
Journal:  J Nucl Med       Date:  1967-08       Impact factor: 10.057

9.  Purification of human erythropoietin.

Authors:  T Miyake; C K Kung; E Goldwasser
Journal:  J Biol Chem       Date:  1977-08-10       Impact factor: 5.157

Review 10.  Immunohistochemistry of central nervous system tumors. Its contributions to neurosurgical diagnosis.

Authors:  J M Bonnin; L J Rubinstein
Journal:  J Neurosurg       Date:  1984-06       Impact factor: 5.115

View more
  4 in total

1.  Histogenesis of stromal cells in cerebellar hemangioblastomas. An immunohistochemical study.

Authors:  I Becker; W Paulus; W Roggendorf
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

Review 2.  Application and implementation of selective tissue microdissection and proteomic profiling in neurological disease.

Authors:  Jay Jagannathan; Jie Li; Nicholas Szerlip; Alexander O Vortmeyer; Russell R Lonser; Edward H Oldfield; Zhengping Zhuang
Journal:  Neurosurgery       Date:  2009-01       Impact factor: 4.654

3.  Mast cells and macrophages in duodenal mucosa of mice overexpressing erythropoietin.

Authors:  Domenico Ribatti; Enrico Crivellato; Beatrice Nico; Diego Guidolin; Max Gassmann; Valentin Djonov
Journal:  J Anat       Date:  2009-08-18       Impact factor: 2.610

4.  Surgical management of haemangioblastoma of the posterior fossa.

Authors:  L Symon; T Murota; M Pell; L Bordi
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.